SCHEMBL28409645

SCHEMBL28409645

CCCc1nn(C)c2c(=O)nc(-c3cc(S(N)(=O)=O)ccc3OCC)[nH]c12

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.75
KDM4E B2RXH2 1/20 0.60
PDE5A O76074 17/20 0.57
PDE3B Q13370 3/20 0.57
PDE3A Q14432 3/20 0.57
PDE2A O00408 2/20 0.57
PDE9A O76083 2/20 0.57
PDE4A P27815 2/20 0.57
PDE6C P51160 2/20 0.57
PDE1A P54750 2/20 0.57
PDE11A Q9HCR9 2/20 0.57
PDE10A Q9Y233 2/20 0.57
ABCC4 O15439 1/20 0.57
ABCC5 O15440 1/20 0.57
PDE6D O43924 1/20 0.57
PDE8A O60658 1/20 0.57
ABCB11 O95342 1/20 0.57
CYP3A4 P08684 1/20 0.57
HTR1A P08908 1/20 0.57
PDE6A P16499 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26766365 0.94 KMT2A (0.66) KMT2AKDM4EPDE5APDE3BPDE3A
SCHEMBL22558019 0.91 KMT2A (0.62) KMT2AKDM4EPDE5APDE3BPDE3A
SCHEMBL29393046 0.91 KMT2A (0.62) KMT2AKDM4EPDE5APDE3BPDE3A
SCHEMBL4369284 0.91 KMT2A (0.62) KMT2AKDM4EPDE5APDE3BPDE3A
SCHEMBL29010393 0.90 KMT2A (0.61) KMT2AKDM4EPDE5APDE3BPDE3A
SCHEMBL22793623 0.89 KMT2A (0.60) KMT2AKDM4EPDE5APDE3BPDE3A
SCHEMBL29010395 0.88 KMT2A (0.58) KMT2AKDM4EPDE5APDE3BPDE3A
Sildenafil SCHEMBL492566 0.86 PDE5A (0.77) PDE5APDE3BPDE3APDE2APDE9A
SCHEMBL28417274 0.86 PDE5A (0.65) KMT2AKDM4EPDE5APDE2APDE9A
SCHEMBL19518061 0.86 PDE5A (0.77) PDE5APDE3BPDE3APDE2APDE9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN claimed
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN disclosed